Primary and secondary prostatic adenocarcinoma of the urinary bladder

被引:10
作者
Mai, KT
Ford, JC
Morash, C
Gerridzen, R
机构
[1] Ottawa Hosp, Div Anat Pathol, Dept Lab Med, Ottawa, ON K1Y 4E9, Canada
[2] Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON K1Y 4E9, Canada
[3] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON K1N 6N5, Canada
关键词
prostatic adenocarcinoma; urinary bladder; prostate-specific antigen;
D O I
10.1053/hupa.2001.23518
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Urinary bladder involvement by prostatic adenocarcinoma (PAC) is not well characterized in the literature. Fifteen consecutive cases of PAC diagnosed in the urinary bladder over a period of 10 years were reviewed. Ah bladder and prostate slides from each patient were evaluated. Eleven patients (group A) had synchronous PAC in the prostate. In these patients, bladder PAC occurred 2 to 11 years after the initial diagnosis of PAC in the prostate and tended to have a higher Gleason score than the original prostatic PAC. Four cases of bladder PAC in group A had areas with features of urothelial carcinoma, with focal positive immunoreactivity for thrombomodulin in 2 cases, Two patients (group B) had undergone radical prostatectomy for PAC 15 years earlier. The lesions in the urinary bladder in both cases showed histopathologic features similar to those seen in the previous prostatic malignancies. Two patients (group C) had histories of previously resected urothelial carcinoma. Bladder PAC was diagnosed at routine follow-up, and repeated prostate biopsy up to 2 years after the diagnosis of bladder PAC showed no evidence of prostatic PAC. PAC in the urinary bladder may be either primary or secondary. Secondary PAC is usually associated with high-grade and high-stage carcinoma in the prostate and may mimic transitional cell carcinoma. Primary bladder lesions may or may not be associated with a history of PAC in the prostate, The prognosis of patients with the primary carcinoma is favorable.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 22 条
[1]   Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma [J].
Bassily, NH ;
Vallorosi, CJ ;
Akdas, G ;
Montie, JE ;
Rubin, MA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (03) :383-388
[2]  
BEAHRS OH, 1992, MANUAL STAGING CANC, P181
[3]  
Bostwick DG, 1998, CANCER, V83, P1995, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1995::AID-CNCR16>3.0.CO
[4]  
2-2
[5]   LATE URINARY-BLADDER METASTASES AFTER RADICAL RESECTION OF PROSTATIC-CARCINOMA [J].
BUCHHOLZ, NP ;
MOCH, H ;
MIHATSCH, MJ .
UROLOGIA INTERNATIONALIS, 1994, 53 (01) :50-52
[6]   PROSTATIC-TYPE POLYPS OF THE LOWER URINARY-TRACT - 3 HISTOGENETIC TYPES [J].
CHAN, JKC ;
CHOW, TC ;
TSUI, MS .
HISTOPATHOLOGY, 1987, 11 (08) :789-801
[7]  
CONOLLY JA, 1996, UROLOGY, V47, P225
[8]   PROSTATIC-TYPE EPITHELIUM IN URINARY-BLADDER - CLINICAL, HISTOLOGIC, AND IMMUNOHISTOCHEMICAL STUDY [J].
DELLADETSIMA, J ;
THEODOROU, C ;
DAPOLLA, Y ;
DIMOPOULOS, C .
UROLOGY, 1990, 36 (05) :445-448
[9]   PROSTATE-SPECIFIC ACID-PHOSPHATASE IMMUNOREACTIVITY IN ADENOCARCINOMAS OF THE URINARY-BLADDER [J].
EPSTEIN, JI ;
KUHAJDA, FP ;
LIEBERMAN, PH .
HUMAN PATHOLOGY, 1986, 17 (09) :939-942
[10]   Morphometric studies of intra-prostatic volume relationships in localized prostatic cancer [J].
Haggman, M ;
Nordin, B ;
Mattson, S ;
Busch, C .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (04) :612-617